期刊文献+

采用定量蛋白质组学技术筛选急性髓系白血病HL-60细胞的甲基化相关基因(英文) 被引量:1

Screening for methylation-silenced genes in acute myeloid leukemia HL-60 cell line by a quantitative proteomic approach
下载PDF
导出
摘要 目的:筛选人急性髓系白血病细胞株HL-60甲基化沉默基因,为揭示白血病的发病机制及防治提供科学依据。方法:应用荧光差异双向凝胶电泳(two-dimensional fluorescence difference gel electro-phoresis,F-2D-DIGE)分离甲基转移酶抑制剂5-杂氮-2-脱氧胞苷(5-aza-2-dC)处理与未处理的HL-60细胞的总蛋白质,Decyder和PDquest图像分析软件识别差异表达蛋白质点,基质辅助激光解吸电离飞行时间质谱(MALDI-TOF MS)技术鉴定差异表达蛋白质。结果:建立了5-aza-2-dC处理与未处理的HL-60细胞蛋白质的F-2D-DIGE图谱,图像分析识别了53个差异表达的蛋白质点,质谱分析鉴定了35个差异表达的蛋白质,其中32个蛋白质在5-aza-2-dC处理后的HL-60细胞中表达上调,3个蛋白质表达下调。结论:35个差异表达蛋白可能与甲基化相关,为白血病的表观遗传学研究提供了有价值的信息。 Objective To screen for new methylation association genes in HL-60 to reveal the pathogenesis of leukemia,and provide important theoretical and scientific basis for the prevention and cure of leukemia.Methods Two-dimensional fluorescence difference gel electrophoresis(F-2D-DIGE) was performed to separate the total proteins from acute myelogenous leukemia(AML) cell line HL-60 cells with or without 5-aza-2-deoxycytidine(5-aza-2-dC) treatment.Imaging software Decyder 6.5 and PDQuest were used to detect the differential expression protein spots,and matrix-assisted laser desorption/ionizaion time-of-flight mas spectrometer(MALDI-TOF MS) was adopted to identify the differential expression proteins.Results F-2D-DIGE maps of 5-aza-2-dC-untreated HL-60 and-treated HL-60 cells were established.A total of 53 differential protein spots were detected,and 35 differential proteins were successfully identified.Of the identified proteins,32 proteins were up-regulated,and 3 proteins were down-regulated in HL-60 cells after 5-aza-2-dC treatment.Conclusion Thirty-five differential proteins may be associated with methylation in HL-60 cell line,which provides the important clues for epigenetic study of leukemia.
出处 《中南大学学报(医学版)》 CAS CSCD 北大核心 2010年第7期641-648,共8页 Journal of Central South University :Medical Science
基金 supported by Outstanding Scholars of New Era from Ministry of Education of Peopde's Republic of China(NECT-07-0861) the Lotus Scholars Program of Hunan Province, P.R. China (2007-362) Scientific and Technological Projects of Department of Public Health of Hunan, P.R. China (B2009123)
关键词 HL-60 甲基化 荧光差异双向凝胶电泳 5-杂氮-2-脱氧胞苷 HL-60 methylation two-dimensional fluorescence difference gel electrophoresis 5-aza-2-deoxycytidine
  • 相关文献

参考文献14

  • 1Yoon J H,Park J A,Kim E K,et al.Improvement of induction remission rate by modifying the dose of idarubicin for relapsed childhood acute lymphoblastic leukemia[J].J Korean Med Sci,2009,24(2):281-288.
  • 2Jones P A,Baylin S B.The fundamental role of epigenetic events in cancer[J].Nat Rev Genet,2002,3 (6):415-428.
  • 3Herman J G,Baylin S B.Gene silencing in cancer in association with promoter hypermethylation[J].N Engl J Med,2003,349(21):2042-2054.
  • 4Wijam P W,Krulder J W M,Huijgens P C,et al.Continuous infusion of low-dose 5-aza-2'-deoxycytidine in elderly patients with high-risk myelodysp lastic syndrome[J].Leukemia,1997,11(Supp 1):S19-S23.
  • 5Willemze B,Suciu S,Archimbaud E,et al.A randomized phase II study on the effects of 5-Aza-2'-deoxycytidine combined with either amsacrine oridarubiein in patients with mlapsed acute leukemia:An EORTC leukemia cooperative group phase II study(06893)[J].Leukemia,1997,11(Suppl):S24-S27.
  • 6Liu Y F,Xiao Z Q,Li M X,et al.Quantitative proteome analysis reveals annexin A3 as a novel biomarker in lung adenocarcinoma[J].J Pathol,2009,217(1):54-64.
  • 7Baylin S B,Herman J G,Graff J R,et al.Alternations in DNA methylation:a fundamental aspect of neoplasia[J].Adv Cancer Res,1988,72:141-196.
  • 8Esteller M.DNA methylation and cancer therapy:new developments and expectations[J].Curr Lin Opin Oncol,2005,17(1):55-60.
  • 9Baylin S B.DNA methylation and gene silencing in cancer[J].Nat Clin Pract Oncol,2005,2(s1):4-11.
  • 10肖艳华,易红,谭潭,梁婷,陈主初,肖志强.5-杂氮-2′-脱氧胞苷抗白血病作用的体外研究[J].中南大学学报(医学版),2008,33(4):344-352. 被引量:6

二级参考文献23

  • 1JieWANG,YanCAI,HaoXU,JunZHAO,XinXU,YaLingHAN,ZhiXiongXU,BaoShengCHEN,HaiHU,MinWU,MingRongWANG.Expression of MRP14 gene is frequently down-regulated in Chinese human esophageal cancer[J].Cell Research,2004,14(1):46-53. 被引量:17
  • 2周涛,陆红,范洪涛,郭秀枝.甲基转移酶抑制剂对Raji细胞系增殖抑制的实验研究[J].武警医学,2004,15(10):730-732. 被引量:1
  • 3Jones PA, Baylin SB. The fundamental role of epigenetic events in cancer[J]. Nat Rev Genet, 2002, (3) :415-428.
  • 4Jones PA, Laird PW. Cancer epigenetics comes of age [ J ]. Nat Genet, 1999, 21 (2) : 163-167. (Review)
  • 5Shteper PJ, Ben-Yehuda D. Methylation of gene promoters in leukemogenesis [ M]. Isr Med Assoc J,2002,4 ( 11 ) : 1066-1071. ( Review )
  • 6Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation [ J ]. N Engl J Med, 2003,349 (21) :2042-2054.
  • 7Baylin SB, Herman JG, Graft JR, et al. Alternations in DNA methylation: a fundamental aspect of neoplasia [ J ]. Adv Cancer Res, 1998,72 : 141-196. (Review)
  • 8W ijermans PW, Krulder J W M, Huijgens PC, et al. Continuous infusion of low-dose 5-A za-2'-deoxycytidine in elderly patients with high-risk myelodysp lastic syndrome[J]. Leukemia, 1997, 11( Supp 11 ) : 19-23.
  • 9Willemze R, Sueiu S, Archimbaud E, et al. A randomized phase E study on the effects of 5-Aza-2'-deoxycytidine combined with either amsacrine oridarubiein in patients with relapsed acute leukemia:An EORTC leukemia cooperative group phase E study (06893) [ J ]. Leukemia, 1997, 11 (Supp 1 1) :S24- 27.
  • 10Leone G, Voso MT, Teofili L, et al . Inhibitors of DNA methylation in the treatment of hematological malignancies and MDS[ J]. J Clin Immunol,2003,109 ( 1 ) :89-102.

共引文献6

同被引文献16

  • 1Cui JW, Li WH, Wang J, et al. Proteomics - based identification of human acute leukemia antigens that induce humoral immune response[ J]. Mol Cell Proteomics ,2005,4( 11 ) : 1718 - 1724.
  • 2Chen CY, Jia JH, Zhang MX. Proteomic analysis on multi - drug re- sistant cells HL- 60/DOX of acute myeloblastic leukemia[J].Chin J Physiol,2005,48 ( 3 ) : 115 - 120.
  • 3Lauten M,Schrauder A, Kardinal C,et al. Unsupervised proteome a- nalysis of human leukaemia cells identifies the Valosin - containing protein as a putative marker for glucocorticoid resistance[ J]. Leuke- mia,2006,20 (5) : 820 - 826.
  • 4Wu W,Tang X, Hu W, et al. Identification and validation of metastasis - associated proteins in head and neck cancer cell lines by two - dimensional electrophoresis and mass spectrometry [ J ]. Clin Exp Metastasis ,2002, 19 (4) : 319 - 326.
  • 5Somasundaram K, Nijaguna MB, Kumar DM. Serum proteomics of glioma : methods and applications [ J 3. Expert Rev Mol Diagn,2009,9 (7) : 695 - 707.
  • 6Zhang G, Zhou B, Zheng, et al. Time course proteomic profile ofrat acute myocardial infarction by SELDI -TOF MS analysis [ J ]. Int J Cardio1,2009,13 1 (2) : 225 - 233.
  • 7He J, Gornbein J, Shen D, et al. Detection of breast cancer bio - Markers in nipple aspirate fluid by SEDIL- TOF and their identi - Fication by combined liquid chromatography - tandem mass spec- tromety[ J]. Int J Oncol,2007 Jan,30( 1 ) : 145 - 154.
  • 8Apweiler R, Aslanidis C, Deufel T, et al. Approaching clinical pro- teomics: current state and future fields of application in fluid proteomics [ J ]. Clin Chem Lab Med,2009,47 ( 6 ) : 724 - 744.
  • 9Chen L, Fatima S, Peng J, et al. SELDI protein chip technology for the detection of serum biomarkers for liver disease[ J]. Protein Pept Lett, 2009,16 (5) : 467 - 472.
  • 10Kern C, Comuel JF, Billard C. Involvement of BAFF and APRIl in the resistance to apoptosis of B - CL1 through an autocrine pathway [ J ]. Blood,2004,103 ( 2 ) : 679 - 688.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部